报价延迟最少15分钟:2026/11/14 14:24 EST
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.94 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.02/--
|
|
企业价值
2.54B
|
| 资产负债 |
|
每股账面净值
0.03
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Regencell Bioscience Holdings Ltd is an early-stage bioscience company that focuses on research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, specifically ADHD and ASD. Its goal is to save and improve the lives of patients, their families and caregivers and become a market leader for the natural and holistic treatment globally. The company operates and manages its business as a single segment - in the research and development of the company's product candidates. |
